74.4700 -0.78 (-1.04%)
NSE Apr 09, 2025 10:31 AM
Volume: 2,985
 

ICICI Securities Limited
Mangalam Drugs & Organics (Mangalam) is one of the largest and most preferred API suppliers for anti-malarial drug manufacturing companies in India and abroad. It is one of the five companies globally to qualify under the Bill Clinton Foundation for supply of anti-malarial drugs. The company's APIs are largely supplied to companies, which participate in WHO tenders and are funded by various global agencies like Clinton Foundation, Gates...
Mangalam Drugs and Organics Ltd. has lost -28.63% in the last 1 Year
More from Mangalam Drugs and Organics Ltd.
Recommended